HK Stock MarketDetailed Quotes

02877 SHINEWAY PHARM

Watchlist
  • 8.410
  • +0.080+0.96%
Market Closed Nov 15 16:08 CST
6.96BMarket Cap5.75P/E (TTM)

SHINEWAY PHARM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
-13.01%2.09B
14.32%4.52B
32.14%2.4B
22.56%3.95B
16.80%1.82B
21.38%3.22B
30.58%1.55B
-1.86%2.66B
-13.02%1.19B
5.28%2.71B
Operating income
-13.01%2.09B
14.32%4.52B
32.14%2.4B
22.56%3.95B
16.80%1.82B
21.38%3.22B
30.58%1.55B
-1.86%2.66B
-13.02%1.19B
5.28%2.71B
Cost of sales
13.49%-514.51M
-10.88%-1.12B
-21.28%-594.72M
-24.48%-1.01B
-20.47%-490.38M
-21.77%-813.21M
-29.74%-407.07M
7.81%-667.86M
20.16%-313.75M
-4.36%-724.43M
Operating expenses
13.49%-514.51M
-10.88%-1.12B
-21.28%-594.72M
-24.48%-1.01B
-20.47%-490.38M
-21.77%-813.21M
-29.74%-407.07M
7.81%-667.86M
20.16%-313.75M
-4.36%-724.43M
Gross profit
-12.85%1.57B
15.51%3.39B
36.17%1.8B
21.90%2.94B
15.50%1.32B
21.25%2.41B
30.88%1.15B
0.32%1.99B
-10.14%876.37M
5.62%1.98B
Selling expenses
20.27%-817.37M
-8.96%-1.98B
-24.29%-1.03B
-21.27%-1.82B
-17.45%-824.8M
-26.51%-1.5B
-24.99%-702.24M
-5.22%-1.19B
1.30%-561.83M
-12.97%-1.13B
Administrative expenses
-4.95%-145.21M
-16.69%-326.5M
-8.13%-138.37M
-9.06%-279.8M
-13.23%-127.97M
6.15%-256.56M
10.65%-113.01M
0.84%-273.36M
9.94%-126.49M
-7.57%-275.66M
Research and development expenses
7.16%-44.75M
5.95%-110.46M
-68.11%-48.2M
-4.21%-117.45M
-14.57%-28.67M
-13.04%-112.71M
-24.03%-25.03M
2.93%-99.71M
55.97%-20.18M
19.83%-102.72M
Impairment and provision
31.27%-4.29M
38.38%-5.44M
-332.16%-6.24M
-25.74%-8.83M
-174.86%-1.44M
97.03%-7.02M
84.94%-525K
-429.75%-236.52M
---3.49M
---44.65M
-Impairment of intangible assets
----
----
----
----
----
----
----
-368.71%-168.73M
----
---36M
-Impairment of property, machinery and equipment
----
----
----
----
----
----
----
---4.07M
----
----
-Goodwill impairment
----
----
----
----
----
----
----
---56.79M
----
----
-Other impairment is provision
31.27%-4.29M
38.38%-5.44M
-332.16%-6.24M
-25.74%-8.83M
-174.86%-1.44M
-1.53%-7.02M
84.94%-525K
20.03%-6.92M
---3.49M
---8.65M
Special items of operating profit
535.09%183.19M
59.44%167.38M
117.03%28.85M
26.71%104.98M
-45.53%13.29M
-3.85%82.85M
-69.69%24.4M
-8.45%86.17M
-2.58%80.5M
142.77%94.13M
Operating profit
20.97%743.76M
38.96%1.14B
73.09%614.85M
32.62%818.56M
7.44%355.23M
121.25%617.22M
35.01%330.63M
-46.96%278.97M
-19.02%244.89M
-1.33%525.96M
Financing cost
-1,567.84%-2.85M
-334.44%-2.74M
50.43%-171K
49.76%-630K
73.42%-345K
92.45%-1.25M
90.28%-1.3M
-524.53%-16.6M
-8,405.73%-13.35M
---2.66M
Special items of earning before tax
114.05%121.17M
6.47%105.51M
0.15%56.61M
-4.84%99.1M
10.64%56.53M
-21.50%104.14M
-27.30%51.09M
11.04%132.66M
47.30%70.28M
-12.19%119.47M
Earning before tax
28.42%862.08M
35.25%1.24B
63.17%671.29M
27.35%917.03M
8.15%411.41M
82.29%720.1M
26.05%380.42M
-38.54%395.02M
-13.76%301.81M
-3.94%642.77M
Tax
-31.02%-235.6M
-39.38%-270.74M
-123.98%-179.82M
-18.86%-194.25M
-11.56%-80.29M
-63.44%-163.43M
-49.65%-71.97M
28.38%-99.99M
22.81%-48.09M
14.48%-139.62M
After-tax profit from continuing operations
27.47%626.48M
34.14%969.51M
48.42%491.47M
29.84%722.77M
7.35%331.12M
88.68%556.67M
21.57%308.46M
-41.36%295.03M
-11.80%253.72M
-0.54%503.15M
Earning after tax
27.47%626.48M
34.14%969.51M
48.42%491.47M
29.84%722.77M
7.35%331.12M
88.68%556.67M
21.57%308.46M
-41.36%295.03M
-11.80%253.72M
-0.54%503.15M
Profit attributable to shareholders
27.47%626.48M
34.14%969.51M
48.42%491.47M
29.84%722.77M
7.35%331.12M
88.68%556.67M
21.57%308.46M
-41.36%295.03M
-11.80%253.72M
-0.54%503.15M
Basic earnings per share
27.69%0.83
33.33%1.28
47.73%0.65
29.73%0.96
7.32%0.44
89.74%0.74
24.24%0.41
-39.06%0.39
-8.33%0.33
3.23%0.64
Diluted earnings per share
27.69%0.83
33.33%1.28
47.73%0.65
29.73%0.96
7.32%0.44
89.74%0.74
24.24%0.41
-39.06%0.39
-8.33%0.33
3.23%0.64
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover -13.01%2.09B14.32%4.52B32.14%2.4B22.56%3.95B16.80%1.82B21.38%3.22B30.58%1.55B-1.86%2.66B-13.02%1.19B5.28%2.71B
Operating income -13.01%2.09B14.32%4.52B32.14%2.4B22.56%3.95B16.80%1.82B21.38%3.22B30.58%1.55B-1.86%2.66B-13.02%1.19B5.28%2.71B
Cost of sales 13.49%-514.51M-10.88%-1.12B-21.28%-594.72M-24.48%-1.01B-20.47%-490.38M-21.77%-813.21M-29.74%-407.07M7.81%-667.86M20.16%-313.75M-4.36%-724.43M
Operating expenses 13.49%-514.51M-10.88%-1.12B-21.28%-594.72M-24.48%-1.01B-20.47%-490.38M-21.77%-813.21M-29.74%-407.07M7.81%-667.86M20.16%-313.75M-4.36%-724.43M
Gross profit -12.85%1.57B15.51%3.39B36.17%1.8B21.90%2.94B15.50%1.32B21.25%2.41B30.88%1.15B0.32%1.99B-10.14%876.37M5.62%1.98B
Selling expenses 20.27%-817.37M-8.96%-1.98B-24.29%-1.03B-21.27%-1.82B-17.45%-824.8M-26.51%-1.5B-24.99%-702.24M-5.22%-1.19B1.30%-561.83M-12.97%-1.13B
Administrative expenses -4.95%-145.21M-16.69%-326.5M-8.13%-138.37M-9.06%-279.8M-13.23%-127.97M6.15%-256.56M10.65%-113.01M0.84%-273.36M9.94%-126.49M-7.57%-275.66M
Research and development expenses 7.16%-44.75M5.95%-110.46M-68.11%-48.2M-4.21%-117.45M-14.57%-28.67M-13.04%-112.71M-24.03%-25.03M2.93%-99.71M55.97%-20.18M19.83%-102.72M
Impairment and provision 31.27%-4.29M38.38%-5.44M-332.16%-6.24M-25.74%-8.83M-174.86%-1.44M97.03%-7.02M84.94%-525K-429.75%-236.52M---3.49M---44.65M
-Impairment of intangible assets -----------------------------368.71%-168.73M-------36M
-Impairment of property, machinery and equipment -------------------------------4.07M--------
-Goodwill impairment -------------------------------56.79M--------
-Other impairment is provision 31.27%-4.29M38.38%-5.44M-332.16%-6.24M-25.74%-8.83M-174.86%-1.44M-1.53%-7.02M84.94%-525K20.03%-6.92M---3.49M---8.65M
Special items of operating profit 535.09%183.19M59.44%167.38M117.03%28.85M26.71%104.98M-45.53%13.29M-3.85%82.85M-69.69%24.4M-8.45%86.17M-2.58%80.5M142.77%94.13M
Operating profit 20.97%743.76M38.96%1.14B73.09%614.85M32.62%818.56M7.44%355.23M121.25%617.22M35.01%330.63M-46.96%278.97M-19.02%244.89M-1.33%525.96M
Financing cost -1,567.84%-2.85M-334.44%-2.74M50.43%-171K49.76%-630K73.42%-345K92.45%-1.25M90.28%-1.3M-524.53%-16.6M-8,405.73%-13.35M---2.66M
Special items of earning before tax 114.05%121.17M6.47%105.51M0.15%56.61M-4.84%99.1M10.64%56.53M-21.50%104.14M-27.30%51.09M11.04%132.66M47.30%70.28M-12.19%119.47M
Earning before tax 28.42%862.08M35.25%1.24B63.17%671.29M27.35%917.03M8.15%411.41M82.29%720.1M26.05%380.42M-38.54%395.02M-13.76%301.81M-3.94%642.77M
Tax -31.02%-235.6M-39.38%-270.74M-123.98%-179.82M-18.86%-194.25M-11.56%-80.29M-63.44%-163.43M-49.65%-71.97M28.38%-99.99M22.81%-48.09M14.48%-139.62M
After-tax profit from continuing operations 27.47%626.48M34.14%969.51M48.42%491.47M29.84%722.77M7.35%331.12M88.68%556.67M21.57%308.46M-41.36%295.03M-11.80%253.72M-0.54%503.15M
Earning after tax 27.47%626.48M34.14%969.51M48.42%491.47M29.84%722.77M7.35%331.12M88.68%556.67M21.57%308.46M-41.36%295.03M-11.80%253.72M-0.54%503.15M
Profit attributable to shareholders 27.47%626.48M34.14%969.51M48.42%491.47M29.84%722.77M7.35%331.12M88.68%556.67M21.57%308.46M-41.36%295.03M-11.80%253.72M-0.54%503.15M
Basic earnings per share 27.69%0.8333.33%1.2847.73%0.6529.73%0.967.32%0.4489.74%0.7424.24%0.41-39.06%0.39-8.33%0.333.23%0.64
Diluted earnings per share 27.69%0.8333.33%1.2847.73%0.6529.73%0.967.32%0.4489.74%0.7424.24%0.41-39.06%0.39-8.33%0.333.23%0.64
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data